3-BroMo-4-hydroxypyridine

Offered by Shanghai Rlavie Technology Co.,ltd, 3-BroMo-4-hydroxypyridine (CAS 36953-41-0) is listed as a pharmaceutical-grade intermediate. It is manufactured in-house rather than sourced from a third party, with sales across major global markets such as North America, Central/South America, Europe, among others. It is produced to recognized quality standards such as the Chinese Pharmacopoeia (ChP), USP, the British Pharmacopoeia (BP), the European Pharmacopoeia (EP), the Japanese Pharmacopoeia (JP), the International Pharmacopoeia (Ph. Int), the Indian Pharmacopoeia (IP). Per the supplier's listing, it is assayed at a minimum of 98% purity.